Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies

Pharmaceutical combination of anti CEACAM6 and TIM3 antibodies

US Patent 12221479 · Granted Feb 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
Intracellular kinase associated with resistance against anti-tumour immune respo2025
Methods of treatment using CCR8 antibodies2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation2024
Anti-CEACAM6 antibodies and uses thereof2024
Anti-CEACAM6 antibodies and uses thereof2024
Cytotoxic T cell response modifiers2023
Anti-CEACAM6 antibodies and uses thereof2023
Anti-CEACAM6 antibodies and uses thereof2023
Substituted pyrrolopyridine-derivatives2022
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB72021